Found 93 presentations matching your search
EMPAGLIFLOZIN AFTER ACUTE MYOCARDIAL INFARCTION
Empagliflozin 10 mg,25 mg
Use of Empagliflozin in ACS: Guideline Perspective
Comparion of Empagliflozin and Dapagliflozin in diabetic treatment for Heart disease patient
Empagliflozin, cardiovascular outcomes, and mortality in type 2 DM
Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors such as Dapagliflozin (Farxiga), Canagliflozi...
Emperor Preserved Trial
T2DM Management
Notes on microvascular and macrovascular DM complication management.
Sodium glucose cotransporter 2 (sglt2) inhibitors and the effect on the heart and chronic kidney dis...
Dapagliflozin
ferozsons
Management of CAD in Diabetes the cardiovascular equivalent is challenging.The slides take you from ...
Types and causes of cardiovascular diseas in diabetes
newer antidiabetics drugs
Anti diabetic drugs
Causes. Pathogenesis of acute coronary syndrome in type 2diabetes
Recent advances in the treatment of diabetes mellitus
STABILITY INDICATING ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR.
Diabetes Mellitus in Ramadhan CME Presentation
diabetes
sglt2i inhibitor and dka
Heart failure
This is a compact slide on Oral Hypoglycaemic Agents (drugs acting against diabetes, both type 1 and...
